Altera Digital Health, a global health IT leader, today announced the launch of Sunrise(TM) Axon, a new solution that delivers normalized, deduplicated, real-time patient information in provider ...
NIAGARA FALLS, N.Y., October 21, 2025--(BUSINESS WIRE)--Altera Digital Health, a global health IT leader, today announced the launch of Sunriseâ„¢ Axon, a new solution that delivers normalized, ...
Axon announced its acquisition of 911 tech provider Prepared earlier this year. This new $625 million buyout of the emergency dispatch and communications tech firm is meant to help Axon craft a public ...
ZAP Surgical Systems, Inc., a pioneer in non-invasive robotic brain surgery, today announced that its award-winning ZAP-Axon(R) Radiosurgery Planning System has received both U.S. FDA 510(k) clearance ...
Many welcome recent US AI expansion plans into the UK. However, alongside jubilation about billions in inward investment come troubling reservations about the environmental cost of the 95 new UK data ...
Nitika Garg does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
On a dry, hot day this summer, Kathryn Barnwell, a retired English professor, marched up the road from her home in Nanaimo, B.C., to take another crack at the mayor. Leonard Krog, a longtime friend of ...
As AI becomes more common and decisions more data-driven, a new(ish) form of information is on the rise: synthetic data. And some proponents say it promises more privacy and other vital benefits. Data ...
Please provide your email address to receive an email when new articles are posted on . Data on medications and vaccines during pregnancy are limited. Vaccines and Medication in Pregnancy Safety ...
New Jersey assemblywoman Andrea Katz is preparing legislation to make data centers in the state pay for the electricity they use. Katz, a Democrat, announced in September that she was introducing a ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results